Industry committee  I'll be very brief. First of all, I want to thank you all for listening to us today. I really do think, as Richard has said, that we have to take some risks to make this happen. The world has really taken risks already to get 5.2 million people onto therapy and has done things

Industry committee  No, that is not what I said at all. Second-line drugs are just as effective, but more expensive.

Industry committee  There is a difference in cost, but not in how effective they are, since they have to be bioequivalent.

Industry committee  Absolutely nothing is stopping them, and each company has a specific program to ensure that their medicines get on the market at a reduced price, meaning a price that is different from the price in the north. Also, these companies have the exact same systems in place to make sure

Industry committee  That amount is for AIDS, malaria and tuberculosis.

Industry committee  Double.

Industry committee  Who need to be treated.

Industry committee  But we have a few problems now. One, again, is the issue that we're not funding the global fund today as we funded it a year ago in order to do this work. With less funding to do double the work...first of all, that's not going to happen. The only way that countries that contri

Industry committee  The numbers in Africa are even greater than the number of people dying of HIV and AIDS, if you look at the straight numbers. In reality, malaria today in Africa is a function of immunity, because when people are immune-compromised, they are more susceptible to malaria and to deat

Industry committee  No. Diarrhea's probably the number one killer of infants, but malaria is the number one killer. Again, it's my HIV education piece here. People don't die of HIV virus; people die of pneumonia. So we could say the same of Africa. People don't die of HIV virus; people who are HIV-i

Industry committee  For sure, in terms of the global fund, and in terms of the program that would access most this type of legislation in order to get the drugs--

Industry committee  They would not only look to break patent, if you would, for HIV, but we do have a serious concern with malaria as well, because the drugs that are not patent-protected are really inferior drugs to those we have available to us throughout the world. So what I use when I go to Afri

Industry committee  They are doing that as well.

Industry committee  What happened in Africa specifically is that the continent has been divided, meaning that the countries who make multilateral donations are responsible for some countries, or parts of countries, and the Americans are responsible for other parts of the countries. So, where we are

Industry committee  The amounts have gone down this year. We were aiming for about $10 billion. The Americans put in $3 billion. So we're talking about a market of around $13 billion today.